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OBJECTIVES: The vulva is the primary site affected in lichen sclerosus, a chronic dermatosis in women that is
histologically characterized by a zone of collagen remodeling in the superior dermis. The normal physiological
properties of the vulva depend on the assembly of collagen types I (COLI), III (COLIII) and V (COLV), which form
heterotypic fibers, and extracellular matrix protein interactions. COLV regulates the heterotypic fiber diameter,
and the preservation of its properties is important for maintaining normal tissue architecture and function.
In the current work, we analyzed the expression of COLV and its relationship with COLI, COLIII, elastic fibers and
extracellular matrix protein 1 in vulvar biopsies from patients with lichen sclerosus.
METHODS: Skin biopsies from 21 patients with lichen sclerosus, classified according to Hewitt histological
criteria, were studied and compared to clinically normal vulvar tissue (N=21). Morphology, immunohistochem-
istry, immunofluorescence, 3D reconstruction and morphometric analysis of COLI, COLIII, COLV deposition,
elastic fibers and extracellular matrix 1 expression in a zone of collagen remodeling in the superior dermis were
performed.
RESULTS: A significant decrease of elastic fibers and extracellular matrix 1 protein was present in the
hyalinization zone of lichen sclerosus compared to healthy controls. The non-homogeneous distribution of
collagen fibers visualized under immunofluorescence in the hyalinization zone of lichen sclerosus and control
skin was confirmed by histomorphometry. Lichen sclerosus dermis shows a significant increase of COLI, COLIII
and COLV expression compared to the healthy controls. Significant inverse associations were found between
elastic fibers and COLV and between COLV and extracellular matrix 1 expression. A direct association was found
between elastic fiber content and extracellular matrix 1 expression. Tridimensional reconstruction of the
heterotypic fibers of the lichen sclerosus zone of collagen remodeling confirmed the presence of densely
clustered COLV.
CONCLUSIONS: Increased deposition of abnormal COLV and its correlation with extracellular matrix 1 and
elastic fibers suggest that COLV may be a trigger in the pathogenesis of lichen sclerosus.
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Lichen sclerosus (LS) is a chronic inflammatory mucocu-
taneous dermatosis (1,2) that predominantly affects women
in the perimenopausal and postmenopausal years. Genetic
and autoimmune factors have been reported in the etiology
of this dermatosis (3). The association with organ-specific
autoimmune disease has suggested that LS may represent an
autoimmune phenomenon (4). Histologically, the collagen
hyalinization zone of the dermis has been used as a grading
system for diagnosis (5). Several alterations of normal
physiology could be responsible for the hyaline zone in LS
dermatosis. For example, the spatial organization of collagen
I (COLI) and III (COLIII) fibers (6) could be abnormally
interlaced with heterotypic fibers and extracellular matrix
(ECM) protein 1. Another possible cause is an absent elastic
system (6). Finally, decreased CD44 expression and changesDOI: 10.6061/clinics/2015(05)09
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in cell-cell and cell-ECM interactions, followed by catabolism
of these ECM components (7,8), could also be involved in
this pathologic process.
Collagen V (COLV) is located in the dermis and basement
membrane. This ECM component is a highly preserved
protein found in many different animal species, which
maintains the highly immunogenic NH2 terminal region
(9,10). This protein is typically not exposed in the ECM, as it
is hidden among COLI and COLIII, together comprising
heterotypic fibers (10). COLV is also essential to the integrity
of the connective tissue, exhibiting different functions
depending on its distribution and molecular isoforms (10).
The COLV molecules contribute to the binding of collagens
to the basal membrane and are important for cell adhesion
and extracellular matrix repair processes (11).
ECM protein 1 (ECM 1) was identified in 1994 as an
85 kDa glycoprotein secreted by a specific lineage of
osteogenic stromal mouse cells, known as MN7 (12).
Subsequently, a human counterpart related to the regulation
of endochondral bone formation and the proliferation of
endothelial cells inducing angiogenesis was found (13). In
addition, ECM 1 acts as ’’biological glue", thus contributing
to the regulation of the basement membrane and organiza-
tion of collagen fibers (14).
Considering that little is known about COLV in LS, in the
present work, we analyzed the expression of this collagen
and its relationships with COLI, COLIII, elastic fibers and
ECM 1 component in vulvar biopsies from patients with LS.
’ MATERIALS AND METHODS
Patient selection and sample collection
All vulvar LS biopsies were obtained in the Division of
Dermatology of the Clinics Hospital of the University of Sao
Paulo, Brazil. Punch biopsies (4 mm–6 mm) included vulvar
epidermis and dermis. LS biopsies (n=21) were obtained
from untreated patients (67.29±12.34 years) with LS
confirmed by histopathological analysis. Control vulvar
biopsies (n=21) were obtained from normal vulva in autopsy
cases (69.48±12.23 years). All patients in the study signed an
informed consent to a research protocol that had been
reviewed and approved by the Medical Ethical Committee of
the Clinics Hospital from the School of Medicine of the
University of São Paulo (No. 0233/09) for the specific study.
Similarly, post-mortem sample use was approved by the
Ethical Committee of the Coroner’s Service of the University
of São Paulo to obtain healthy controls from autopsy cases.
Histology, immunohistochemistry
and immunofluorescence
For histological, immunohistochemical and immunofluor-
escence evaluation, biopsies were fixed in 10% buffered
formaldehyde for 24 h and embedded in paraffin. Five-
micrometer-thick sections were obtained and stained with
hematoxylin and eosin (H & E) and a Verhoeff stain for
elastic fibers; they were then classified independently by two
separate pathologists according to the Hewitt criteria (5).
For immunohistochemistry, the sections were hydrated
and submitted to pepsin-mediated antigen retrieval for
20 min at 37 ˚C. After that, endogenous peroxidase was
blocked by immersing the sections in a 3% hydrogen
peroxide solution (3  5 min) and washed twice with
phosphate-buffered saline (PBS, pH 7.4). Nonspecific binding
of immunoglobulins with tissue proteins was blocked by
washing with casein for 5 min at room temperature, followed
by incubation with rabbit polyclonal antibody directed
against ECM 1 (Santa Cruz Biotechnology Inc., Dallas, Texas,
USA, 1:50 dilution). The Novolink amplification kit (Leica
Inc., Newcastle, UK) was used for signal amplification, and
3,3’-diaminobenzidine tetrachloride (0.25 mg dissolved in
1 mL of 0.02% hydrogen peroxide) was used as a precipitat-
ing substrate for signal detection. The specimens were then
counterstained with Harris hematoxylin. The specificity of
the primary antibody was confirmed with the appropriate
reagent controls (omitting the primary antibody or substitut-
ing non-immune serum for the primary antibody in the
staining protocol), which revealed no staining.
For immunofluorescence, the sections were mounted on
3-aminopropyltriethoxysilane (Sigma Chemical Co., St. Louis,
MO, USA), dewaxed in xylol and hydrated in graded ethanol.
Antigen retrieval was accomplished using enzymatic treatment
with porcine pepsin (10.000 dry unit/ml) (Sigma Chemical Co.,
St. Louis, MO, USA) in acetic acid buffer at 0.5 N for 30 min at
37 ˚C. For the immunodetection of COLI, COLIII and COLV,
nonspecific sites were blocked with 3% hydrogen peroxide for
25 min, then blocked with avidin and biotin (Vector Labora-
tories, Inc., Burlingame, CA, USA) for 10 min each, and finally
blocked with 5% skim milk in PBS for 30 min. The skin
specimens were incubated overnight at 4 ˚C with rabbit
polyclonal antihuman COLV (1:50), rabbit polyclonal antihuman
COLIII (1:200) or rabbit polyclonal antihuman COLI antibodies
(Rockland Immunochemicals Inc., PA, USA, 1:150) (15). The skin
sections were washed in PBS with 0.05% Tween20 and
incubated for 90 min at room temperature with goat anti-rabbit
IgG antibody conjugated with fluorescein (Sigma Chemical Co.,
St. Louis, MO, USA) 1:50 diluted in a PBS solution containing
0.006% Evans blue. Finally, the samples were mounted on
buffered glycerol and analyzed using fluorescence microscopy
(Olympus BX51, Olympus Co, Tokyo, Japan). For negative and
autofluorescence controls, sections were incubated with normal
rabbit serum and PBS instead of the specific antibody. We used
tongue sections as positive controls.
Histomorphometry
We used the Image ProPlus software to quantify ECM 1
expression and COLI, COLIII, COLV, and elastic fibers in the
hyalinization band. Briefly, the image analysis system
consisted of an Olympus camera (Olympus Co, St. Laurent,
Quebec, Canada) attached to an Olympus microscope
(Olympus BX51, Olympus Co, Tokyo, Japan). The images
taken were sent to an LG monitor (Oculus TCX, Coreco, Inc.,
St. Laurent, Quebec, Canada) and downloaded to a
computer (Pentium 1330 MHz, Intel, Santa Clara, CA,
USA). The images were then processed with software (Image
Pro Plus 6.0, Media Cybernetics, Rockville, MD, USA) (16).
The fraction area of collagen and elastic fibers was measured
in an area delimited by the basement membrane, including
papillary and reticular dermis partially covering the micro-
scopic field observed at 400X magnification. The threshold
for collagen and elastic fibers was established for all slides
after the contrast was enhanced to the point at which the
fibers were easily identified by the green (collagen fibers)
and black (elastic fibers) bands. The collagen and elastic
fibers’ fraction area was expressed as the ratio of the
numbers of measured fibers divided by the total area studied
(16). All microscopic fields for each slide were quantified,
and the results are expressed as the means of these fields.
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The fraction area of ECM 1 was determined in five fields,
including the superficial epidermis and small vessels from
papillary and reticular dermis, which were randomly selected
and analyzed under 400X magnification. We measured the
intensity of immunostaining around blood vessels and in the
epidermis. Only the vessels with strong expression and medium
intensity were considered positive, and their sum was divided
by the total number of vessels in the field. In the epidermis,
these areas were also considered positive, and their area was
divided by the total area of the epidermis in the field.
Three-dimensional reconstruction of collagen fibers
COLI, COLIII and COLV spatial organization was evaluated
by confocal microscopy. Sections were processed in the same
way as for immunofluorescence. The skin specimens were
incubated overnight at 4 ˚C with rabbit polyclonal antihuman
COLV (1:50), rabbit polyclonal antihuman COLIII (1:200) or
rabbit polyclonal antihuman COLI antibodies (Rockland
Immunochemicals Inc., Limerick, PA, USA) (1:150) (15). The
skin sections were washed in PBS with 0.05% Tween20 and
incubated for 90 min at room temperature with goat anti-rabbit
IgG antibody ALEXA 488 (Invitrogen, Life Technology, Grand
Island, NY, USA) diluted 1:200 in PBS. The nuclei were stained
with DAPI (40,6-diamidino-2-phenylindole, Invitrogen, Life
Technology, Grand Island, NY, USA; 1:200 in PBS) by
incubating for 15 min at room temperature. Finally, the samples
were mounted on buffered glycerol and analyzed using a
confocal laser-scanning microscope (Zeiss LSM 510/UVGOAL,
Jena, Germany) for the 3D reconstruction of collagen fibers. For
Figure 1 - Histological, histochemical, immunohistochemical and quantitative expression of elastic fibers and ECM 1 in the dermis of
healthy controls and lichen sclerosus. (A) A health control biopsy shows a uniform pattern of papillary and reticular dermis; (B) fine
black elastic fibers are seen in the papillary and reticular dermis (arrows) and (C) the regular brownish color of ECM 1 expression is in
the superficial epidermis and small vessels of the reticular dermis (arrows). (D and G) Lichen sclerosus exhibits upper dermal
homogenization with subepidermal separation; (E) disappearance of elastic fibers were seen, whereas (E) elastic fibers in the reticular
to deep dermis mostly appeared normal or showed a mild increase just beneath the hyalinized zone (arrows); (F) mild or absent
brownish color of ECM 1 expression in superficial epidermis and small vessels (arrows). (H) A significant decrease in elastic fibers is
present in the hyalinization zone of LS compared to control skin. (I) In addition, the hyalinization zone from LS skin presents a
significant decrease of ECM 1 protein expression compared to healthy controls (po0.001). (H&E: A, X40; D, X40; G, X100 magnification);
(Resorcin: B and E X200 magnification); (ECM immunostaining: C, X200; F, X200 magnification) (Der=dermis, Epi=epidermis, Ves=vessel).
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negative and autofluorescence controls, the sections were
incubated with normal rabbit serum and PBS instead of the
specific antibody. We used tongue sections as positive controls.
Statistical analysis
The statistical analyses were performed using the Statis-
tical Package for the Social Sciences version 20.0 (SPSS;
Chicago, IL, USA). Data are expressed as means and
standard deviations for continuous variables and percen-
tages for categorical variables. The regular distribution of the
data in the groups was assessed with the Kolmogorov-
Smirnov test, and we used the Mann-Whitney U test to
compare the continuous variables not paired and non-
parametric and Student’s t-test for paired and parametric
continuous variables. When significant differences were
identified between the groups for a given variable, the
Pearson correlation coefficient for a parametric distribution
of data and the Spearman correlation for non-parametric
data were performed. The level of significance was po0.05.
’ RESULTS
The typical histopathologic appearances of the normal
control (n=21) and patient skin (n=21) with elastic fiber and
Figure 2 - Immunofluorescence, tridimensional reconstruction and quantitative expression of COLI, COLIII and COLV in the dermis of
healthy controls and vulvar LS. (A) Dermis from a healthy control showing loosely arranged, green-stained COLI fibers assuming a
basket-weave pattern in the dermis, along the basement membrane and sometimes around small vessels (thin arrows). (D) Vulvar LS
dermis presents a similar pattern to the control, in which a basket-weave pattern of green-stained COLI fibers is also observed in the
dermis (arrows), with loosely arranged fibers along the basement membrane (thick arrows), although small vessel enhancement is more
prominent (thin arrows). (B) Dermis from a healthy control, showing COLIII thin fibers predominantly around the small vessels (thin
arrows) and sparsely distributed in the basement membrane (thick arrows) and dermis (arrows). (E) In vulvar LS dermis, the thin green
fibers are distributed around the small vessels (thin arrows); however, in contrast with the healthy control, this collagen permeates the
dermis (arrows) and is irregularly distributed along the basement membrane (thick arrows). (C) COLV 3D-reconstruction in the dermis of
a healthy control, with loosely arranged, thin COLV fibers showing a wavy distribution throughout the dermis (arrows), along the
basement membrane (thick arrows) and around the small vessels (thin arrows). (F) Vulvar LS dermis presents dense COLV fibers forming
irregular aggregates tightly packed in the dermis (arrows), exhibiting band distribution along the basement membrane (thick arrows)
and present around the small vessels (thin arrows). (G, H, I) vulvar LS dermis shows a significant increase of COLI, COLIII and COLV
expression compared to healthy controls (p=0.03, po0.01 and po0.01, respectively). (Immunofluorescence: A-F; X400, original
magnification); (Der=dermis, Epi=epidermis, Ves=vessel).
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ECM 1 expression are shown in Figure 1 (Panels A, B, C, E)
stained by H & E, Verhoeff and immunohistochemistry.
In the normal control skin (Figure 1A), thin elastic fibers
ran perpendicularly in the superficial dermis and horizon-
tally in the papillary and reticular dermis (Figure 1B). In
vulval LS, we found a subepidermic hyalinization zone
(Figure 1D) with sparse elastic fibers (Figure 1E and 1G) and
a discrete increase in elastic fibers just beneath the hyalinized
superficial dermis.
In healthy controls, ECM 1 immunostaining occurs in the
superficial epidermis and the small vessels of the papillary
and reticular dermis (Figure 1C). In contrast, vulval LS tissue
exhibits decreased immunoexpression of ECM 1 in the
superficial epidermis and small vessels of the subepidermic
hyalinization zone, with a discrete increase just beneath the
hyalinized superficial dermis (Figure 1F).
Figure 1 (Panels H and I) shows the graphic expression of
the measurements of elastic fibers and ECM 1 protein in the
hyalinization zone of LS and in the control skin. As
expected, a significant decrease in elastic fibers was found
in the hyalinization zone of LS tissue compared to the
control skin (Figure 1H; po0.001). Furthermore, the hyali-
nization zone from LS skin presented significantly
decreased ECM 1 protein expression compared to the
healthy controls (Figure 1I). No difference was found for
ECM 1 expression in the epidermis and beneath the
hyalinized superficial dermis from LS and control speci-
mens. No significant difference was revealed between the
elastic fibers just beneath the hyalinized superficial dermis
and those of the healthy controls.
Figure 2 (Panels A to F) presents COLI, COLIII and
COLV fibers reconstructed by confocal microscopy in the
hyalinization zone of LS and control specimens. Regarding
COLI, in the control skin, the fibers were loosely arranged
along the basement membrane (Figure 2A), assuming
a honeycomb pattern in the papillar and part of the
reticular layers and occasionally enhancing the walls of
small vessels. In contrast, in the hyalinization zone of LS
tissue, thick and fragmented COLI fibers were densely
aggregated in the basement membrane (Figure 2D), the
papillary layer, part of the reticular layer, and the small
vessels (Figure 2D, arrows), modifying the typical his-
toarchitecture of the dermis. Thin fibers of COLIII were
visualized predominantly around the small vessels and
were sparsely distributed in the basement membrane and
dermis from healthy controls (Figure 2B). In contrast, the
hyalinization zone in LS skin exhibited thin fibers of COLIII
irregularly distributed along the basement membrane,
involving small vessels (Figure 2E, arrows) and diffusely
permeating the papillary layer. Analysis of COLV in the
control specimens indicated loose, thin fibers in a homo-
geneous and linear distribution along the basement
membrane (Figure 2C) and around vessels (Figure 2C, thin
arrow). In the dermis, COLV staining followed a wavy
distribution coincident with the maintenance of normal
tissue architecture (Figure 2C). In contrast, the hyalinization
zone in LS specimens exhibited distorted and fragmented
fibers of COLV (Figure 2F), as did the basement membrane and
small vessels (Figure 2F, arrows).
Graphic representations of the measurements of COLI,
COLIII and COLV in LS and control skin are presented in
Figure 2 (Panels G, H, I). The non-homogeneous distribution
of collagen fibers visualized under immunofluorescence in
the hyalinization zone of LS and control skin was confirmed
by histomorphometry. COLI, COLIII and COLV expression
were significantly increased in the LS dermis compared to
the healthy controls (p=0.03, po0.01 and po0.01, respec-
tively; Figures 2 G, H, I).
Significant inverse associations were found between elastic
fibers and COLV (R=-7.77; po0.01) and between COLV and
ECM 1 expression (R=-7.56; po0.01). A direct association
was found between elastic fibers and ECM 1 expression
(R=6.50; p=0.01).
’ DISCUSSION
In the current work, we observed a nearly complete
absence of elastic fibers in the upper dermal homogenized
zone in LS. Similar findings have been previously reported
(17–19). The mechanism for the disappearance of elastic
fibers has not been proven, but it may be triggered by the
elastolytic changes induced by elastase-type proteases
secreted from dermal fibroblasts or activated macrophages
(17,20). This hypothesis is supported by Abbas and
colleagues, who found prominent elastophagocytosis below
the homogenized zone in extragenital LSA patients (21).
Using quantitative approaches, we found no significant
difference between the elastic fibers just beneath the hyali-
nized dermis and those in the reticular deep dermis. This
finding contrasts with previous reports, which employed
subjective or qualitative approaches to show a prominent
dermal increase in elastic fibers in some cases of vulval LS
(22). These authors interpreted their case as the coexistence of
nevus elasticus and vulval LSA. Another similar case was
described by Allan and colleagues (23), who found LS
involving a surgical scar, characterized by the uncommon
presence of prominent nodules of elastin in the reticular
dermis. These authors reported nodular elastosis as an
atypical characteristic distinct to LS but related to scar
formation. To further explore this relationship, Shiba and
colleagues (19) reported an increase in elastic fibers in the mid-
to lower dermis in contrast with a decrease or disappearance
of elastic fibers in the superficial hyalinized dermis. The group
found that the increase in elastic fibers varies and concluded
that an increase in elastic fibers in the mid- to lower dermis
may reflect a repairing process in response to the degraded
upper dermal elastic fibers, which could be related to the
pathogenesis of LS. The difference between our findings and
these previous reports is likely related to our employ of
objective quantitative approaches to evaluate the elastic fiber
content in our cases.
In the present work, we also analyzed the expression of
COLV and its relation with COLI, COLIII, elastic fibers and
ECM 1 protein in vulvar biopsies from patients with LS. The
main finding was that COLV was distorted and over-
deposited in the hyalinization band of vulvar LS, suggesting
that COLV is an important regulator of the cutaneous
plaques and has potential as a target for future treatments.
An increased amount of COLV was found and, according to
tridimensional reconstruction, showed a structural disorga-
nization of the fibrils with a different density clustering. In
this context, COLV fibers may contribute to cutaneous
plaque formation in LS, as the distribution and organization
of the collagen system affects the mechanical properties of
the tissues. Moreover, imperfect glycosylation of COLV
fibrils may also explain the plaques, as glycosylated
hydroxylysine residues avoid lateral triple-helical collagen
assembly and thus the development of ordered fibrils (24).
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COLV fibrils are critical for controlling the development of
a functional skin matrix (25). The triple helices of COLV are
found hidden inside the heterotypic fibril, and the preserved
amino terminal globular domain projects from the surface,
regulating the diameter of these fibers (26). Interestingly,
COLI and COLIII fibers were also densely clustered in LS
tissue, indicating that COLV had likely lost its regulatory
function. These findings were expected because COLI and
COLIII are normally both up-regulated during skin remodel-
ing. In normal skin, small amounts of COLV are expressed as
thin fibrils in the basement membranes for binding with
stromal collagen, which is important for cell adhesion and
the matrix repair process (27). In the current work, the
increased numbers of COLI, COLIII, and COLV fibers found
in LS tissue were associated with the subepidermic hyalini-
zation band, likely due to a high co-polymerization among
the fibers, resulting in a heterotypic assembly incapable of
controlling fibril structure and collagen fibrillogenesis.
Existing reports have shown a direct correlation between
the extent of the hyalinization band reaction and the
progression of LS, which is similar to the increased COLV
found in our study (26).
Our results also showed that an increase in COLV fibers
was associated with a decrease in ECM 1 expression by
cutaneous microvessels, suggesting that an increased bind-
ing of COLV to epitopes on endothelial cells reduces the
synthesis of ECM 1 by these cells. COLV is a potential trigger
antigen because it induces scleroderma in rabbits (28–32) and
is related to lung transplant rejection in animals (33) and
human patients (34). Furthermore, the induction of oral
tolerance by COLV suppresses acute and chronic lung
rejection in animals (35). Similarly, nasal tolerance induced
by COLV in experimental SSc reverted skin (36) and
pulmonary remodeling processes (37). These findings rein-
force studies that suggested that immunological factors are
involved in and responsible for all of the steps of disease.
In fact, the relationship between organ-specific autoimmune
disease and LS has indicated LS as an autoimmune
phenomenon. Chan and colleagues (38) reported that the
sera of affected individuals contain circulating IgG auto-
antibodies to the ECM 1 protein. The passive transfer of these
autoantibodies may reproduce histological and immunophe-
notypical features of LS skin (39). Another question that
could be resolved is the relationship between high COLV
synthesis, the hyalinization band, and decreased ECM 1
blood vessel expression, which leads to decreased angiogen-
esis, increased hypoxia and decreased nutrient flow. Thus,
the increased expression of COLV in LS may be a primary
event, whereas decreased ECM 1 expression may be a
secondary event. Regardless of the mechanism, immunos-
taining of LS for COLV and ECM 1 provided important
information about LS.
To our knowledge, this study is the first to investigate
COLV and ECM 1 signals in the skin from patients with LS,
therefore limiting comparison of the results.
In summary, decreased staining of elastic fibers in the
upper dermal homogenized zone in LS tissue was associated
with highly and abnormally expressed COLV and decreased
ECM 1 expression. The increased COLV and decreased
ECM 1 expression may reflect a bad immunogenic repair
process in response to the disappearance of elastic fibers in
the upper homogenized dermis and may offer a better
understanding of the pathogenesis of vulval LS. COLV fiber
density and ECM 1 expression in vulval LS may have
therapeutic implications for controlling this disorder.
Furthermore, strategies aimed at preventing high COLV
synthesis, or local responses to low ECM 1 expression, may
be useful for LS treatment. Further confirmation of these
conclusions will require a larger-scale study in a randomized
and prospective trial.
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